Dr Murray Grossman & Dr David Wolk of Penn Medicine clear the air about Alzheimer’s & Frontotemporal dementia #FTD - two similar but very different diseases.
Clinical trials data is increasing in complexity as well as volume day by day. With limited time and our limited capabilities, it is not humanly possible to analyse such huge data sets completely.
The US FDA has approved a pathbreaking gene therapy treatment for a form of inherited blindness. Luxturna is the first of any such treatment for a genetic condition approved in the US.
The “Washington My Health My Data Act” (Substitute House Bill 1155) is an act that establishes strict regulations on the collection, sharing, and selling of consumer health data in Washington. Signed On April 27th, the act…
We are thrilled to share some exciting news with you! Our innovative work in the field of space health research has been prominently featured as – not one, but two groundbreaking papers – in the latest edition…
The DIA 2024 conference concluded, and we are thrilled to share the highlights of our participation. A prominent event – attended by 4K+ people and featuring 220 sessions with more than 500 speakers across 13 engaging…